ABSTRACT
Abstract Objective Ameloblastoma is a representative odontogenic tumor comprising several characteristic invasive forms, and its pathophysiology has not been sufficiently elucidated. A stable animal experimental model using immortalized cell lines is crucial to explain the factors causing differences among the subtypes of ameloblastoma, but this model has not yet been disclosed. In this study, a novel animal experimental model has been established, using immortalized human ameloblastoma-derived cell lines. Methodology Ameloblastoma cells suspended in Matrigel were subcutaneously transplanted into the heads of immunodeficient mice. Two immortalized human ameloblastoma cell lines were used: AM-1 cells derived from the plexiform type and AM-3 cells derived from the follicular type. The tissues were evaluated histologically 30, 60, and 90 days after transplantation. Results Tumor masses formed in all transplanted mice. In addition, the tumors formed in each group transplanted with different ameloblastoma cells were histologically distinct: the tumors in the group transplanted with AM-1 cells were similar to the plexiform type, and those in the group transplanted with AM-3-cells were similar to the follicular type. Conclusions A novel, stable animal experimental model of ameloblastoma was established using two cell lines derived from different subtypes of the tumor. This model can help clarify its pathophysiology and hasten the development of new ameloblastoma treatment strategies.
Subject(s)
Animals , Female , Mice , Ameloblastoma/pathology , Disease Models, Animal , Neoplasms, Experimental/pathology , Proteoglycans , Time Factors , Immunohistochemistry , Cells, Cultured , Reproducibility of Results , Collagen , Laminin , Cell Line, Tumor , Green Fluorescent Proteins/analysis , Drug CombinationsABSTRACT
Abstract In the muscle invasive bladder cancer (MIBC) standard of care treatment only patients presenting a major pathological tumor response are more likely to show the established modest 5% absolute survival benefit at 5 years after cisplatin-based neoadjuvant chemotherapy (NAC). To overcome the drawbacks of a blind NAC (i.e. late cystectomy with unnecessary NAC adverse events) with potential to survival improvements, preclinical models of urothelial carcinoma have arisen in this generation as a way to pre-determine drug resistance even before therapy is targeted. The implantation of tumor specimens in the chorioallantoic membrane (MCA) of the chicken embryo results in a high-efficiency graft, thus allowing large-scale studies of patient-derived "tumor avatar". This article discusses a novel approach that exploits cancer multidrug resistance to provide personalized phenotype-based therapy utilizing the MIBC NAC dilemma.
Subject(s)
Humans , Animals , Urinary Bladder Neoplasms/drug therapy , Carcinoma/drug therapy , Urothelium/pathology , Chorioallantoic Membrane/pathology , Neoplasms, Experimental/drug therapy , Phenotype , Urinary Bladder Neoplasms/pathology , Carcinoma/pathology , Neoadjuvant Therapy , Medical Illustration , Neoplasm Seeding , Neoplasms, Experimental/pathologyABSTRACT
Platelet activating factor is a lipid mediator of inflammation, and in recent decades, it has emerged as an important factor in tumor outcomes. Platelet activating factor acts by specific binding to its receptor, which is present in both tumor cells and cells that infiltrate tumors. Pro-tumorigenic effects of platelet activating factor receptor in tumors includes promotion of tumor cell proliferation, production of survival signals, migration of vascular cells and formation of new vessels and stimulation of dendritic cells and macrophages suppressor phenotype. In experimental models, blocking of platelet activating factor receptor reduced tumor growth and increased animal survival. During chemotherapy and radiotherapy, tumor cells that survive treatment undergo accelerated proliferation, a phenomenon known as tumor cell repopulation. Work from our group and others showed that these treatments induce overproduction of platelet activating factor-like molecules and increase expression of its receptor in tumor cells. In this scenario, antagonists of platelet activating factor markedly reduced tumor repopulation. Here, we note that combining chemo- and radiotherapy with platelet activating factor antagonists could be a promising strategy for cancer treatment.
Subject(s)
Animals , Platelet Membrane Glycoproteins/antagonists & inhibitors , Cell Proliferation/drug effects , Cell Proliferation/radiation effects , Neoplasms, Experimental/therapy , Combined Modality Therapy/methods , Cell Line, Tumor , Neoplasms, Experimental/pathology , Neovascularization, Pathologic/drug therapy , Neovascularization, Pathologic/therapyABSTRACT
AbstractObjective: to perform the translation into Brazilian Portuguese and cultural adaptation of the Face, Legs, Activity, Cry, Consolability revised (FLACCr) scale, with children under 18 years old, affected by cerebral palsy, presenting or not cognitive impairment and unable to report their pain.Method: methodological development study of translation into Portuguese and cultural adaptation of the FLACCr. After approval by the ethics committee, the process aimed at translation and back-translation, evaluation of translation and back-translation using the Delphi technique and assessment of cultural equivalence. The process included the five categories of the scale and the four application instructions, considering levels of agreement equal to or greater than 80%.Results: it was necessary three rounds of the Delphi technique to achieve consensus among experts. The agreement achieved for the five categories was: Face 95.5%, Legs 90%, Activity 94.4%, Cry 94.4% and Consolability 99.4%. The four instructions achieved the following consensus levels: 1st 99.1%, 2nd 99.2%, 3rd 99.1% and 4th 98.3%.Conclusion: the method enabled the translation and cultural adaptation of the FLACCr. This is a study able to expand the knowledge of Brazilian professionals on pain assessment in children with CP.
ResumoObjetivo:realizar a tradução para a língua portuguesa do Brasil e adaptação cultural da escala Face, Legs, Activity, Cry, Consolability revised(FLACCr), com crianças de até 18 anos de idade, acometidas por paralisia cerebral, apresentando ou não comprometimento cognitivo e impossibilitadas de relatar sua dor.Método:estudo de desenvolvimento metodológico de tradução para o português e adaptação cultural da FLACCr. Após aprovação do comitê de ética, o processo contemplou tradução e retrotradução, avaliação da tradução e da retrotradução utilizando a técnica de Delphi e avaliação da equivalência cultural. O processo incluiu as cinco categorias da escala e as quatro orientações de aplicação, considerando nível de concordância igual ou maior a 80%.Resultados:foram necessários três ciclos da técnica de Delphi para consenso entre os juízes. A concordância obtida para as cinco categorias foi: Face 95,5%, Pernas 90%, Atividade 94,4%, Choro 94,4% e Consolabilidade 99,4%. As quatro orientações alcançaram os seguintes níveis de consenso: 1ª 99,1%, 2ª 99,2%, 3ª 99,1% e 4ª 98,3%.Conclusão:o método possibilitou o desenvolvimento da tradução e adaptação cultural da FLACCr. Sendo um estudo capaz de ampliar o conhecimento de profissionais brasileiros sobre a avaliação da dor em crianças com PC.
ResumenObjetivo:realizar la traducción para el portugués de Brasil y la adaptación cultural de la escala, Face, Legs, Activity, Cry, Consolability revised(FLACCr), con niños menores de 18 años de edad, afectados por la parálisis cerebral, presentando o no deterioro cognitivo y que no pueden comunicar su dolor.Método:estudio de desarrollo metodológico de traducción al portugués y adaptación cultural de la FLACCr. Después de la aprobación por el comité de ética, el proceso incluyó la traducción y retrotraducción, evaluación de la traducción y retrotraducción utilizando la técnica Delphi y evaluación de la equivalencia cultural. El proceso incluyó las cinco categorías de la escala y las cuatro orientaciones de aplicación, teniendo en cuenta nivel de concordancia igual o superior al 80%.Resultados:fueron necesarios tres ciclos de la técnica Delphi para el consenso entre los jueces. La concordancia obtenida para las cinco categorías fue: Cara 95,5%, Piernas 90%, Actividad 94,4%, Llanto 94,4% y Capacidad de Consuelo 99,4%. Las cuatro orientaciones alcanzaron los siguientes niveles de consenso: 1ª 99,1%, 2ª 99,2%, 3ª 99,1% y 4ª 98,3%.Conclusión:el método permitió el desarrollo de la traducción y adaptación cultural de la FLACCr. Este estudio fue capaz de aumentar el conocimiento de los profesionales brasileños en la evaluación del dolor en niños con PC.
Subject(s)
Animals , Rats , Graft Rejection/immunology , Neoplasms, Experimental/immunology , Cell Line, Tumor , Graft Rejection/genetics , Graft Rejection/pathology , Neoplasm Transplantation , Neoplasms, Experimental/genetics , Neoplasms, Experimental/pathology , Rats, Inbred Lew , Rats, WistarABSTRACT
OBJECTIVE: To evaluate differences in children's eating behavior in relation to their nutritional status, gender and age. METHODS: Male and female children aged six to ten years were included. They were recruited from a private school in the city of Pelotas, Rio Grande do Sul, southern Brazil, in 2012. Children´s Eating Behaviour Questionnaire (CEBQ) subscales were used to assess eating behaviors: Food Responsiveness (FR), Enjoyment of Food (EF), Desire to Drink (DD), Emotional Overeating (EOE), Emotional Undereating (EUE), Satiety Responsiveness (SR), Food Fussiness (FF) and Slowness in Eating (SE). Age-adjusted body mass index (BMI) z-scores were calculated according to the WHO recommendations to assess nutritional status. RESULTS: The study sample comprised 335 children aged 87.9±10.4 months and 49.3% had normal weight (n=163), 26% were overweight (n=86), 15% were obese (n=50) and 9.7% were severely obese (n=32). Children with excess weight showed higher scores at the CEBQ subscales associated with "food approach" (FR, EF, DD, EOE, p<0.001) and lower scores on two "food avoidance" subscales (SR and SE, p<0.001 and p=0.003, respectively) compared to normal weight children. Differences in the eating behavior related to gender and age were not found. CONCLUSIONS: "Food approach" subscales were positively associated to excess weight in children, but no associations with gender and age were found. .
OBJETIVO: Avaliar diferenças no comportamento alimentar infantil em função do estado nutricional, do sexo e da idade. MÉTODOS: O estudo incluiu crianças na faixa de seis a dez anos, de ambos os sexos, de uma escola privada em Pelotas (RS), em 2012. Para avaliar o comportamento alimentar usaram-se as subescalas do questionário Children's Eating Behaviour Questionnaire (CEBQ): resposta à comida (FR), prazer de comer (EF), desejo de beber (DD), sobreingestão emocional (EOE), subingestão emocional (EUE), resposta à saciedade (SR), seletividade (FF) e ingestão lenta (SE). Avaliou-se o estado nutricional por meio do escore-z do IMC/idade. RESULTADOS: Participaram 335 crianças de 87,9±10,4 meses. Apresentaram eutrofia 49,3% (n=163), sobrepeso 26% (n=86), obesidade 15% (n=50) e obesidade grave 9,7% (n=32). Crianças com excesso de peso tiveram maior pontuação nas subescalas de "interesse pela comida" (FR, EF, DD, EOE, p<0,001) e menor pontuação nas subescalas de "desinteresse pela comida" (SR e SE, p<0,001 e p=0,003, respectivamente), se comparadas com as crianças com peso adequado. Não foram observadas diferenças no comportamento alimentar segundo sexo e idade. CONCLUSÕES: Observou-se que comportamentos alimentares que refletem "interesse pela comida" estão associados positivamente ao excesso de peso, mas não foi encontrada associação com o sexo e a idade da criança. .
Subject(s)
Animals , Female , Humans , Mice , Aniline Compounds/pharmacology , Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Drug Discovery , Microtubules/drug effects , Neoplasms, Experimental/drug therapy , Protein Kinase Inhibitors/pharmacology , Pyrimidines/pharmacology , Receptor Protein-Tyrosine Kinases/antagonists & inhibitors , Water/chemistry , Aniline Compounds/chemistry , Aniline Compounds/chemical synthesis , Antineoplastic Agents/chemistry , Antineoplastic Agents/chemical synthesis , Cell Line, Tumor , Cell Proliferation/drug effects , Dose-Response Relationship, Drug , Drug Screening Assays, Antitumor , HeLa Cells , Mice, Inbred BALB C , Mice, Nude , Neoplasms, Experimental/pathology , Protein Kinase Inhibitors/chemistry , Protein Kinase Inhibitors/chemical synthesis , Pyrimidines/chemistry , Pyrimidines/chemical synthesis , Receptor Protein-Tyrosine Kinases/metabolism , Solubility , Structure-Activity RelationshipABSTRACT
OBJECTIVE: Vitamin D deficiency (VDD) in pregnant women and their children is an important health problem with severe consequences for the health of both. Thus, the objectives of this review were to reassess the magnitude and consequences of VDD during pregnancy, lactation and infancy, associated risk factors, prevention methods, and to explore epigenetic mechanisms in early fetal life capable of explaining many of the non-skeletal benefits of vitamin D (ViD). DATA SOURCE: Original and review articles, and consensus documents with elevated level of evidence for VDD-related clinical decisions on the health of pregnant women and their children, as well as articles on the influence of ViD on epigenetic mechanisms of fetal programming of chronic diseases in adulthood were selected among articles published on PubMed over the last 20 years, using the search term VitD status, in combination with Pregnancy, Offspring health, Child outcomes, and Programming. DATA SYNTHESIS: The following items were analyzed: ViD physiology and metabolism, risk factors for VDD and implications in pregnancy, lactation and infancy, concentration cutoff to define VDD, the variability of methods for VDD detection, recommendations on ViD replacement in pregnant women, the newborn and the child, and the epigenetic influence of ViD. CONCLUSIONS: VDD is a common condition among high-risk pregnant women and their children. The routine monitoring of serum 25(OH)D3 levels in antenatal period is mandatory. Early preventive measures should be taken at the slightest suspicion of VDD in pregnant women, to reduce morbidity during pregnancy and lactation, as well as its subsequent impact on the fetus, the newborn and the child. .
OBJETIVO: Deficiência de vitamina D (DVD) nas gestantes e seus filhos é problema de saúde, com consequências graves à saúde de ambos. Assim, esta revisão visou reavaliar a magnitude e as consequências da DVD na gestação, lactação e infância, fatores de risco associados, métodos de prevenção, além de explorar os mecanismos epigenéticos na vida fetal capazes de explicar benefícios não-esqueléticos da vitamina D (ViD). FONTES DE DADOS: Selecionaram-se artigos originais, de revisão e consensos com nível elevado de evidência para decisões clínicas relacionadas à DVD na saúde das gestantes e seus filhos e artigos sobre sua ação sobre os mecanismos epigenéticos da programação fetal de doenças crônicas na vida adulta, publicados no PubMed nos últimos 20 anos, empregando-se VitD status, e em combinação com Pregnancy, Offspring health, Child outcomes e Programming. SÍNTESE DOS DADOS: Abordou-se fisiologia, metabolismo, fatores de risco para a DVD e implicações na gravidez, lactação e infância, concentração de corte para definir DVD, variabilidade de métodos na sua detecção, recomendações sobre a reposição de ViD nas gestantes, no recém-nascido e na criança, bem como sobre ter as influências epigenéticas da ViD. CONCLUSÕES: DVD é frequente entre gestantes de alto risco e seus filhos. Monitorar rotineiramente os níveis séricos de 25(OH)D3 no período antenatal é imperativo. Medidas preventivas precoces devem ser instituídas à menor suspeita de DVD na gestante, para reduzir morbidades durante a gestação e a lactação, bem como seu posterior impacto sobre o feto, o recém-nascido e na infância. .
Subject(s)
Animals , Humans , Mice , Antineoplastic Agents/pharmacology , Benzothiazoles/pharmacology , Neoplasms, Experimental/drug therapy , Sulfonamides/pharmacology , Antineoplastic Agents/chemistry , Antineoplastic Agents/chemical synthesis , Benzothiazoles/chemistry , Cell Proliferation/drug effects , Dose-Response Relationship, Drug , Drug Screening Assays, Antitumor , Mice, Inbred BALB C , Mice, Nude , Models, Molecular , Molecular Structure , Neoplasms, Experimental/pathology , Structure-Activity Relationship , Sulfonamides/chemistry , Tumor Cells, CulturedABSTRACT
Anticancer potential of Moringa oleifera L. extracts have been well established. However, there are no reports on the isolated molecules/fractions from these extracts which are responsible for the anticancer/cytotoxic activity. Thus, in the present study, we explored the same. The n-hexane, chloroform, ethyl acetate, methanol extracts of the M. oleifera leaves and 15 fractions (F1 to F15) of ethyl acetate extract were evaluated for their in vitro and in vivo anticancer activity using Hep-2 cell lines and Dalton’s lymphoma ascites model in mice, respectively. Among the tested samples, the F1 fraction showed potential cytotoxic effect in Hep-2 cell lines with a CTC50 value of 12.5 ± 0.5 µg/ml. In vivo studies with the doses 5 and 10 mg/kg, p.o. demonstrated significant reduction in body weight and increased the mean survival time compared to the control group. These results were also comparable to the standard, 5-Fluorouracil, treated animals. We have also successfully isolated and characterized the anticancer fraction, F1 from the leaves of M. oleifera L.
Subject(s)
Acetates/chemistry , Animals , Antineoplastic Agents/isolation & purification , Antineoplastic Agents/pharmacology , Cell Line, Tumor , Cell Survival/drug effects , Chlorocebus aethiops , Chemical Fractionation/methods , Chloroform/chemistry , Female , Hep G2 Cells , Hexanes/chemistry , Humans , Inhibitory Concentration 50 , Methanol/chemistry , Moringa oleifera/chemistry , Neoplasms, Experimental/drug therapy , Neoplasms, Experimental/pathology , Plant Extracts/isolation & purification , Plant Extracts/pharmacology , Survival Analysis , Time Factors , Vero CellsABSTRACT
In this study, we aimed to establish the prevalence and risk factors relating to gastrointestinal helminthiasis, and to characterize the sanitary management practiced among sheep herds in the Sertão region of the state of Paraíba, northeastern Brazil, based on factors that condition the ways of controlling these parasites in these herds. The research was carried out between April and July 2012. We visited 54 farms, where fecal and blood samples were individually collected from 465 animals. On each farm, a questionnaire was applied to gather information on variables relating to potential risk factors. The prevalence of sheep gastrointestinal helminthiasis in the region was 75.9%. At least one animal tested positive for this helminthiasis on 53 (98.1%) of the 54 farms evaluated. The eggs per gram of feces (EPG) analysis showed the following infection burdens: 51.8% with mild infection, 27.1% moderate infection, 9.9% heavy infection and 11.2% fatal infection. Among the sheep farms visited, anthelmintics were used on 81.5% (p <0.05). The most relevant risk factor in this study was the farm area, because it defines the area available for grazing animals. Properties with many animals and little pasture area, which are the most abundant type in the Sertão region of Paraíba, tend to have high prevalence of gastrointestinal helminthiasis, because the animals are more prone to reinfection. The Sertão region of Paraíba presents high prevalence of gastrointestinal helminthiasis among sheep, and the farm area is the most relevant risk factor for the development of these parasites.
Objetivou-se determinar a prevalência e os fatores de risco para as helmintoses gastrintestinais, caracterizando o manejo sanitário sob fatores condicionantes das formas de controle dessas parasitoses em rebanhos de ovinos da região do Sertão da Paraíba. A pesquisa foi desenvolvida no período de abril a julho de 2012. Foram visitadas propriedades, utilizando-se 465 animais, sendo coletadas individualmente amostras de fezes e sangue durante as visitas. Em cada propriedade, foi aplicado questionário para a coleta de informações acerca de variáveis que atuariam como possíveis fatores de risco. Observou-se que a prevalência das helmintoses gastrintestinais de ovinos na região do Sertão da Paraíba foi de 75,9%. Pelo menos um animal foi positivo para essas helmintoses, em 53 (98,1%) das 54 propriedades avaliadas. A análise de OPG (Ovos Por Gramas de Fezes) demonstrou que 51,8% dos animais apresentaram infecção leve, 27,1% infecção moderada, 9,9% infecção pesada e 11,2% infecção fatal. A utilização de anti-helmínticos ocorreu em 81,5% das propriedades (p <0,05). O fator de risco mais relevante neste estudo foi a área da propriedade, porque delimita a área de pastejo do animal. Propriedades com muitos animais e pouca área de pastejo, que são as mais abundantes no Sertão da Paraíba, tendem a apresentar alta prevalência de helmintoses gastrintestinais, pois os animais estão mais propensos à reinfecção. A região do Sertão da Paraíba apresenta uma elevada prevalência de helmintoses gastrintestinais em ovinos, e a área das propriedades é o fator de risco mais relevante para o desenvolvimento dessas parasitoses.
Subject(s)
Animals , Humans , Mice , Genes, Tumor Suppressor/physiology , /physiology , Aneuploidy , Apoptosis/physiology , Caspase 9 , Caspase Inhibitors , Cell Cycle/physiology , Cell Division/physiology , Cyclins/metabolism , Cytochrome c Group/metabolism , Green Fluorescent Proteins , Gene Expression Regulation, Neoplastic/genetics , Gene Expression Regulation, Neoplastic/physiology , Genes, Dominant/physiology , Genes, cdc/physiology , Genes, myc/physiology , Homozygote , Luminescent Proteins , Lung/pathology , Lymphoma/metabolism , Lymphoma/pathology , Mice, Knockout , Mice, Transgenic , Mutation/genetics , Neoplasms, Experimental/metabolism , Neoplasms, Experimental/pathology , Ploidies , /metabolismABSTRACT
In vitro anticancer potential of methanolic and aqueous extracts of whole plants of Mentha arvensis, M. longifolia, M. spicata and M. viridis at concentration of 100 µg/ml was evaluated against eight human cancer cell lines — A-549, COLO-205, HCT-116, MCF-7, NCI-H322, PC-3, THP-1 and U-87MG from six different origins (breast, colon, glioblastoma, lung, leukemia and prostate) using sulphorhodamine blue (SRB) assay. Methanolic extracts of above-mentioned Mentha Spp. displayed anti-proliferative effect in the range of 70-97% against four human cancer cell lines, namely COLO-205, MCF-7, NCI-H322 and THP-1; however, aqueous extracts were found to be active against HCT-116 and PC-3. The results indicate that Mentha Spp. contain certain constituents with cytotoxic properties which may find use in developing anticancer agents.
Subject(s)
Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Cell Survival/drug effects , Dose-Response Relationship, Drug , Humans , Mentha/chemistry , Mentha/classification , Neoplasms, Experimental/drug therapy , Neoplasms, Experimental/pathology , Plant Extracts/pharmacology , Species SpecificityABSTRACT
Anticancer potential of Piper longum fruit against human cancer cell lines (DU-145 prostate, A549 lung, THP-1 leukemia, IGR-OVI-1 ovary and MCF-7 breast) as well as its in vitro and in vivo biochemical efficacy in AlCl3-induced hepatotoxicity were evaluated in the rats. Dried samples were extracted with several solvents using soxhlet apparatus. Flavonoid content in chloroform, benzene, ethyl alcohol and aqueous extracts of fruit was 19, 14, 12 and 11 μg quercetin equivalent/mg of sample, respectively. Hexane extracts exhibited 90-92% cytotoxicity against most of the test cell lines (A549, THP-1, IGR-OVI-1 and MCF-7), while benzene extract displayed 84-87% cytotoxicity against MCF-7, IGR-OV-1 and THP-1 cell lines. Among extracts, hexane, benzene and acetone extracts demonstrated considerable cytotoxicity (91-95%) against A549 (lung cancer) cell line in Sulforhodamine B dye (SRB) assay. Cell cycle analysis revealed that hexane, benzene and acetone extracts produced 41, 63 and 43% sub-G1 DNA fraction, demonstrating cell cycle inhibitory potential of these extracts against A549 cell line. Chloroform, ethyl alcohol and aqueous extracts displayed 71, 64 and 65% membrane protective activity, respectively in lipid peroxidation inhibition assay. P. longum fruit extracts also ameliorated AlCl3-induced hepatotoxicity, as indicated by alterations observed in serum enzymes ALP, SGOT and SGPT activity, as well as creatinine and bilirubin contents. In conclusion, study established the cytotoxic and hepatoprotective activity in P. longum extracts.
Subject(s)
Animals , Antineoplastic Agents/administration & dosage , Apoptosis/drug effects , Cell Cycle Checkpoints/drug effects , Cell Line, Tumor , Chlorides , Dose-Response Relationship, Drug , Chemical and Drug Induced Liver Injury/etiology , Chemical and Drug Induced Liver Injury/physiopathology , Chemical and Drug Induced Liver Injury/prevention & control , Fruit/chemistry , Humans , Male , Metals , Neoplasms, Experimental/drug therapy , Neoplasms, Experimental/pathology , Piper/chemistry , Plant Extracts/administration & dosage , Rats , Rats, Wistar , Treatment OutcomeABSTRACT
En el estudio del cáncer, se utilizan diversas líneas celulares, cada una de ellas con características propias. Una de esas líneas tumorales es la variante multirresistente a drogas del tumor TA3. Si bien, existen diversos estudios con esta línea tumoral, no existe una descripción morfológica detallada de esta, ni tampoco que se observe el efecto del Celecoxib, un inhibidor de COX-2 sobre este tejido. Se usaron 18 ratones divididos en 3 grupos, los cuales recibieron: Inoculación de PBS; inoculación de células tumorales TA3; inoculación de células tumorales + tratamiento con Celecoxib (1000 ppm), respectivamente. Los ratones fueron sacrificados y procesados histológicamente para ser teñidos con H&E, PAS y Arteta. El estudio reveló que tumor muestra una marcada heterogeneidad, algunas áreas de necrosis y una neovascularización central y periférica. Además, Celecoxib redujo significativamente la invasión tumoral en el hígado (p < 0,05). Otros órganos no sufrieron diferencias significativas cuando eran comparados con el grupo tratado. Los resultados son similares a descripciones parciales realizadas previamente y son comparables a otras líneas tumorales. Se cree que la vía de administración del fármaco es crítica para la interpretación de los resultados. Estos resultados son importantes para la discusión de otras investigaciones en donde Celecoxib es usado como un fármaco antiangiogénico y sirve como base para futuras investigaciones con esta línea tumoral.
In the study of cancer diverse cellular lines are in use, each with its own characteristics. One of these tumor lines is the TA3 tumor variant, multi resistant to drugs. Although diverse studies exist in reference to this tumor line, there are no detailed morphological descriptions of this one, nor those that observe the effect of Celecoxib, a COX-2 tissue inhibitor. We used 18 mice divided in 3 groups that received PBS inoculation; TA3 tumor cell inoculation; cell tumor inoculation + treatment with Celecoxib (1000ppm) respectively. The mice were sacrificed and histologically processed with H & E, PAS and Arteta stain. The study revealed that tumor showed a marked heterogeneity, some areas of necrosis and central and peripheral neovascularization. Furthermore, Celecoxib significantly reduced tumor invasion in the liver (p< 0.05). Other organs did not show significant differences when compared with the treated group. The results are similar to partial descriptions realized in the past and are comparable to other tumor lines. It is estimated that the route of medication administration is critical for result interpretation. These results are important in the discussion of other research where Celecoxib is used as an antiangiogenic drug and serves as base for future research within this tumor line.
Subject(s)
Animals , Female , Mice , Celecoxib/administration & dosage , /administration & dosage , Cell Line, Tumor , Neoplasms, Experimental/pathology , Drug Resistance, Neoplasm , Liver/pathology , Neoplasm Invasiveness , Neoplasms, Experimental/drug therapy , Lung/pathologyABSTRACT
La línea celular TC-1 se ha utilizado en la evaluación de la inmunoterapia antitumoral. No existen reportes sobre el efecto de las células TC-1 en tejidos adyacentes cuando se implantan en ratones C57BL/6. El objetivo de este trabajo fue evaluar la interacción entre las células TC-1 implantadas y las fibras musculares adyacentes. Se emplearon 8 ratones con células TC-1 implantadas y 3 ratones sin células. Se colectó el sitio del implante de las células tumorales a 10 días, las muestras se procesaron para microscopia de luz y electrónica de transmisión. Se realizaron tinciones con HyE y tricrómico de Masson, histoquímica con PAS, e inmunohistoquímica para identificar citoqueratinas, actina específica de músculo y metaloproteinasa de la matriz-9 (MMP-9). También se comparó el diámetro de las fibras musculares en ambos grupos de estudio. En el análisis histológico se observaron masas de células TC-1 que infiltran el tejido muscular y separan a las fibras entre sí. Las fibras musculares mostraron variaciones en la intensidad de la tinción y disminución de su diámetro. Se observaron masas de células tumorales TC-1 que invaden la fibra hacia el interior y logran atravesar la lámina externa y el sarcolema que las rodea. Se observó positividad a MMP-9 en el citoplasma de las células TC-1, y en el espacio entre las células tumorales y las fibras musculares. En el análisis ultraestructural se observó fragmentación y variaciones en el grosor de la lámina externa y vesículas subsarcolemales en el sitio en donde las células TC-1 invaden las fibras.Ahí, las células TC1 emiten proyecciones de membrana similares a pseudópodos....
TC-1 cells implanted in C57BL/6 mice are a model for evaluation of anti-tumor immunotherapy. To date there are no reports on the effect of implanted TC-1 cells upon neighboring striated muscle cells. The objective of this work was to evaluate the morphology of the interaction established among the implanted cells and the striated muscle cells. The study was carried out as follows: 8 adult C57BL/6 mice received 5x104 cells IP. As a control, 3 mice received no cells. 10 days after cells injection, no signs of tumor are present yet, and the site of cells injection was collected for morphological studies. Samples were processed for light and transmission electron microscopy. Histological sections were stained with H & E, Masson trichromic method, PAS histochemistry and immunohistochemistry for cytocheratins AE1/AE3, muscle specific actin and for matrix metalloproteinase-9. Cross section diameter of muscle sections was compared among experimental and control groups. The histological evaluation showed groups of tumor cells, infiltrating the spaces among muscle fibers. Muscle fibers showed variations in the cross section diameter as well as in the staining pattern. TC-1 cells were seen very close to muscle cells, invading the lamina externa and sarcolema to finally form groups of cells located within the sarcoplasm. This finding was demonstrated by the specific immunolabel for each kind of cell. Reactivity for metalloproteinase-9 was observed within the tumor cells and in the space mediating between the tumor cells and the muscle fiber. At the ultrastructural level, variations of the thickness of lamina externa were observed, as well as interruptions of this structure. Sarcolema also showed fragmentation, and close to these sites a number of subsarcolemmal vesicles were seen. In the vicinity of the muscle fiber, TC-1 cells formed membrane projections directed towards muscle membrane...
Subject(s)
Animals , Muscle, Skeletal/pathology , Neoplasms, Experimental/pathology , T-Lymphocytes, Cytotoxic , Cell Line, Tumor , Immunohistochemistry , Neoplasm InvasivenessABSTRACT
Platelet aggregation around migrating cancer cells protects them against the activity of natural killer cells (NKCs). The inability of immune system to response results in the progression of malignant diseases. This study was designed to evaluate the effects of resveratrol (3, 4', 5-trihydroxystilbene) on platelet aggregation and NKCs activity. Experiments were designed to evaluate the platelet aggregation, production of thromboxane B2 (TXB2), estimation of expression of the platelet receptor GpIIb/IIIa (major biological markers for platelet aggregation) and functional activity of the NKCs against the K562 cancer cell line after incubation with various concentrations of reveratrol. Resveratrol at a concentration of 3 × 10-3Μ completely inhibited platelet aggregation (p<0.05), decreased TXB2 levels (p<0.05) and inhibited the expression of receptor GpIIb/IIIa in non-stimulated platelets (p<0.05). At the same concentration, it increased the NKCs cytotoxic activity at an average rate of 319 ± 34, 450 ± 34 and 62 ± 2.4% (p<0.05) in the NKC/targets cells ratios of 12.5:1, 25:1 and 50:1, respectively. Thus, resveratrol not only completely inhibited platelet aggregation and reduced TXB2 levels and expression of receptor GpIIb/IIIa, but also increased the cytotoxic activity of NKCs in vitro and thus increased the susceptibility of tumor cells to NKCs. Thus, resveratrol can be used as an additional supplement to modulate the immune system and to inhibit platelet aggregation in thromboembolic episodes. Further clinical investigation in vivo could lead to specific concentrations that may maximize the beneficial effect of resveratrol.
Subject(s)
Antineoplastic Agents, Phytogenic/administration & dosage , Apoptosis/drug effects , Apoptosis/immunology , Cell Communication/drug effects , Cell Communication/immunology , Dose-Response Relationship, Drug , Humans , K562 Cells , Killer Cells, Natural/drug effects , Killer Cells, Natural/immunology , Neoplasms, Experimental/drug therapy , Neoplasms, Experimental/immunology , Neoplasms, Experimental/pathology , Platelet Aggregation/drug effects , Platelet Aggregation/immunology , Platelet Aggregation Inhibitors/administration & dosage , Stilbenes/administration & dosage , Treatment OutcomeABSTRACT
Reports remain insufficient on whether and how prostate-specific membrane antigen (PSMA) can influence in vivo osseous metastasis of prostate cancer (PCa). In the present study, the authors induced stable expression of PSMA in mouse PCa cell line RM-1. In vivo osseous metastasis was induced in 37 6-week-old female C57BL/6 mice weighing 22.45 ± 0.456 g. RM-1 cells were actively injected into the femoral bone cavity, leading to bilateral dissymmetry of bone density in the femoral bone. Tumor cells were also detected in bone tissue by pathological examination. The impact on bone density was demonstrated by the significant difference between animals injected with RM-PSMA cells (0.0738 ± 0.0185 g/cm²) and animals injected with RM-empty plasmid cells (0.0895 ± 0.0241 g/cm²). The lytic bone lesion of the RM-PSMA group (68.4%) was higher than that of the control group (27.8%). Immunohistochemistry showed that the expression of both vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) was distinctly higher in the RM-PSMA group than in the control group, while ELISA and Western blot assay indicated that VEGF and MMP-9 were higher in the RM-PSMA group compared to the control group (in vitro). Thus, the present study proposed and then confirmed for the first time that PSMA can promote in vivo osseous metastasis of PCa by increasing sclerotic destruction of PCa cells. Further analyses also suggested that PSMA functions positively on the invasive ability of RM-1 by increasing the expression of MMP-9 and VEGF by osseous metastases in vivo.
Subject(s)
Animals , Female , Male , Mice , Antigens, Surface/metabolism , Bone Neoplasms/secondary , Glutamate Carboxypeptidase II/metabolism , Prostatic Neoplasms/pathology , Antigens, Surface/pharmacology , Bone Density/drug effects , Bone Density/physiology , Bone Neoplasms/pathology , Cell Line, Tumor , Glutamate Carboxypeptidase II/pharmacology , Immunohistochemistry , Matrix Metalloproteinase 9/metabolism , Neoplasms, Experimental/metabolism , Neoplasms, Experimental/pathology , Prostatic Neoplasms/metabolism , Vascular Endothelial Growth Factor A/metabolismABSTRACT
OBJETIVO: Analisar os efeitos das soluções de ácido acetil salicílico (aspirina) e de ácido acético, in vitro, sobre células em suspensão do carcinoma VX-2, verificando-se as mesmas causam a morte das células neoplásicas. MÉTODOS: Procedeu-se a incubação das células tumorais VX-2 (107 células/ml) com diferentes concentrações do ácido acetil salicílico (2,5% e 5%) e de ácido acético (2,5% e 5%), sendo estudada a viabilidade celular pelo teste do azul tripian a cada 5 minutos; procedeu-se à análise à microscopia ótica. RESULTADOS: Observou-se que o percentual de viabilidade das células tumorais foi progressivamente diminuindo, sendo que ao final de 30 minutos todas as células neoplásicas estavam inviáveis em todas as soluções e concentrações utilizadas. CONCLUSÃO: Com base neste modelo experimental e com a metodologia empregada, concluiu-se que in vitro, estas soluções causam a morte (inviabilidade) das células neoplásicas.
Subject(s)
Animals , Rabbits , Acetic Acid/therapeutic use , Aspirin/therapeutic use , Cell Death , Indicators and Reagents/therapeutic use , Neoplasms, Experimental/drug therapy , Cell Survival/drug effects , Drug Combinations , Drug Screening Assays, Antitumor/methods , Microscopy, Fluorescence , Neoplasms, Experimental/pathologyABSTRACT
Barrett's esophagus is a premalignant condition of esophageal adenocarcinoma. Inducible nitric oxide synthase (iNOS) is induced by cytokines and can generate locally high concentrations of nitric oxide (NO), whose metabolites can mediate genotoxicity and influence multistage carcinogenesis by causing DNA damage. Therefore, we evaluated the immunolocalization and expression of iNOS in surgically induced rat Barrett's esophagus. Esophagoduodenal anastomosis was performed in rats for inducing reflux of duodenal contents. Rats were killed at postoperative 10, 20, 30 and 40 weeks. We examined histologic changes and iNOS expression in esophagus by immunohistochemistry and reverse transcription-poly-merase chain reaction. Eighty six percent of experimental rats showed Barrett's esophagus above esophagoduodenal junction. iNOS immunoreactivity was clearly observed in the epithelial cells of Barrett's esophagus, predominantly at the apical surface of epithelial cells. Cytoplasmic staining was also seen only in atypical Barrett's esophagus. iNOS mRNA was detected only in the lower esophagus of experimental group. In conclusion, this study suggests that iNOS has some roles on Barrett's esophagus formation.
Subject(s)
Animals , Male , Rats , Anastomosis, Surgical , Barrett Esophagus/enzymology , Cytoplasm/metabolism , DNA Damage , Disease Models, Animal , Duodenum/enzymology , Esophagus/metabolism , Immunohistochemistry , Models, Anatomic , Neoplasms, Experimental/pathology , Nitric Oxide/metabolism , Nitric Oxide Synthase/biosynthesis , RNA/metabolism , RNA, Messenger/metabolism , Rats, Sprague-Dawley , Reverse Transcriptase Polymerase Chain Reaction , Time FactorsABSTRACT
La manipulación traumática del colon portador de una neoplasia, durante la ejecución de una colectomía laparoscópica podría aumentar la exfoliación de células malignas dentro de la cavidad peritoneal, y por consiguiente ser una de las causas de los implantes cutáneos. Objetivo: Desarrollar un modelo de cáncer colónico experimental con similitud al del hombre y determinar si la manipulación laparoscópica instrumental del carcinoma de colon y recto comparada con la laparotomía, aumenta la exfoliación de células malignas en la cavidad peritoneal, instrumental y trócares. Material y Métodos: Se desarrolló un protocolo de cáncer colorrectal experimental con inyección subcutánea de 1-2 Dimethylhydrazina a una dosis de 20 mg/kg de peso, semanalmente y durante 20 semanas, en 40 ratas Wistar, sexo masculino. Se operaron a la semana 21º, dividiéndolas en 2 grupos (1 y 2). Grupo 1 (n 23) sometidas a laparotomía y manipulación instrumental del colon. Grupo 2 (n 17) se efectuó neumoperitoneo con CO2 hasta una presión de 12 mm Hg, laparoscopia y manipulación instrumental del colon y recto. Un tercer grupo lo constituyeron las ratas controles (n 5). Se realizó citología de: líquido de lavado peritoneal pre y post manipulación intestinal, del instrumental convencional y laparoscópico, de la aguja de Verres y de los trócares. Se efectuó el estudio histológico del colon y recto, ganglios mesentéricos, hígado y peritoneo. Resultados: El 80 por ciento de las ratas desarrollaron adenocarcinomas de colon. No existió diferencia significativa entre la exfoliación celular de ambos grupos de animales. Conclusiones: El carcinoma colorrectal inducido por la 1-2 Dimethylhydrazina tiene características muy similares al del ser humano y es un modelo válido para la investigación. La manipulación instrumental con una prolija técnica durante los procedimientos laparoscópicos no aumenta la exfoliación celular
Subject(s)
Humans , Animals , Rats , Adenocarcinoma/chemically induced , Bronchoscopy/adverse effects , Colorectal Neoplasms/pathology , Neoplasm Metastasis/physiopathology , Neoplasm Seeding , Neoplasms, Experimental/pathology , Colorectal Neoplasms/chemically induced , Dimethylhydrazines/adverse effects , Disease Models, Animal , Neoplasm Recurrence, Local , Peritoneal Lavage , Pneumoperitoneum, Artificial/adverse effects , Rats, Wistar , Skin Neoplasms/secondaryABSTRACT
Through energy minimization using molecular mechanics force field four ruthenium cordinate complexes have been synthesized. Compound I to IV showed antineoplastic activity with varying degree on EAC bearing mice. Mode of action may be through inhibition of antioxidant property of tumor cell as evident from lipid peroxidase activity. Among the complexes Bis pyridine tetrachloro ruthenium exhibits highest order of activity with respect to increase mean survival time, inhibition of tumour volume, total blood count, hemoglobin and lipid peroxidase activity.
Subject(s)
Animals , Antineoplastic Agents/chemical synthesis , Drug Design , Mice , Neoplasms, Experimental/pathology , Ruthenium Compounds/chemistryABSTRACT
The finding of reporter gene expression in muscle cells after intramuscular injection of a reporter gene containing DNA has suggested that injection of a certain gene in its naked form could induce an expression of the injected gene. The result proposed the concept, namely DNA or genetic vaccine technology, that injection of an antigen gene could induce a specific immune response against the antigen. Although the concept was initially applied to vaccination technology, the result also means that administration of cytokine genes with anti-tumor activity could exert their functions when they are applied as a naked form of DNA. To test the possibility, plasmid vector containing granulocyte macrophage-colony stimulation factor (GM-CSF) and interleukin-12 (IL-12) genes, which are known as one of the most potent anti-tumor cytokines, were constructed and injected into mice together with syngeneic tumor cells. When the cytokine gene containing plasmid was injected on the same day of tumor cell injection, a tumor mass developed in 4 out of 5 mice tested. Even among the 4 mice, the tumor mass of a mouse disappeared 2 weeks after tumor development. In addition, tumor generation was significantly delayed in cytokine gene injected mice and the average tumor size was about 51.5% that of vector control injected mice. These results suggested that tumor treatment through the injection of multiple cytokine genes with potent anti-tumor activity significantly inhibits tumor development and growth, and that the method could be considered as one of the tools for efficient tumor treatment.
Subject(s)
Mice , Animals , Colonic Neoplasms/pathology , Colonic Neoplasms/epidemiology , Gene Transfer Techniques , Genes, Tumor Suppressor , Granulocyte-Macrophage Colony-Stimulating Factor/genetics , Incidence , Interleukin-12/genetics , Mice, Inbred BALB C , Neoplasm Transplantation , Neoplasms, Experimental/pathology , Neoplasms, Experimental/epidemiologyABSTRACT
Experiments on rat rhabdomyosarcomas R1H were performed to evaluate the therapeutic potential of a simultaneous radiation-hyperthermia treatment of superficially growing tumours. Tumours were heated locally with infrared-A radiation and irradiated in the middle of the heating period. After a treatment with 32 Gy in 8 fractions combined with 8 heat fractions of 43 degrees C, 1hr, during 4 weeks, tumours showed an enhanced regression and growth delay in comparison to radiation alone. A thermal enhancement ratio (TER) of 1.4 was determined. Acute skin reactions were of minor importance. In conclusion, a simultaneous treatment of superficial tumours with infrared-A-hyperthermia and radiation at a therapy unit is relatively easy to perform and enhances considerably the therapeutic efficacy of a radiation treatment.